Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Review article: Biomedical intelligence

Vol. 144 No. 1718 (2014)

Is the Eichenholtz classification still valid for the diabetic Charcot foot?

  • Ernst Adolf Chantelau
  • Gotthard Grützner
DOI
https://doi.org/10.4414/smw.2014.13948
Cite this as:
Swiss Med Wkly. 2014;144:w13948
Published
20.04.2014

Summary

In his 1966 monograph “Charcot joints”, Sidney N. Eichenholtz (1909–2000) described “three well defined stages … in the course and development of a Charcot joint”, based on plain X-rays of 68 patients. Since then, medical imaging has advanced very much: computed tomography and magnetic resonance imaging (MRI) scans exceed plain X-ray by far in detecting foot fractures and other injuries. The earliest, nondeforming, X-ray-negative inflammatory stage of the acute Charcot joint of the diabetic foot can be visualised only by use of MRI. This stage, which Eichenholtz evidently failed to recognise, will heal without significant arthropathy, if treated in time. By contrast, the stages considered by Eichenholtz inevitably result in major arthropathy and foot deformity. Hence, superseding the Eichenholtz classification is overdue. We propose an MRI-based classification comprising two severity grades (0 and 1, according to absence/presence of cortical fractures) and two stages (active/inactive, according to presence/absence of skeletal inflammation).

References

  1. Eichenholtz SN. Charcot joints. With a foreword by P.D.Wilson. Springfield (Ill): Charles C. Thomas;. 1966.
  2. Sinacore DR, Withrington NC. Recognition and management of acute neuropathic (Charcot) arthropathies of the foot and ankle. J Orthop Sports Phys Ther. 1999;29:736–46.
  3. Anonymous. Charcot joints. By Sidney N. Eichenholtz, M.A.,M.D.,F.A.C.S., with a Foreword by Philip D. Wilson, M.D. Pp.xiv+227.1966. Springfield, Illinois: Charles C. Thomas, Publisher. Price 15.75. J Bone Joint Surg. (Br) 1966;48–B: 611.
  4. Anonymous. Charcot joints. Sidney N. Eichenholtz. $15.75. 246 pages. Charles C. Thomas. Springfield, Ill.,1966. Diabetes. 1966;15:700.
  5. Edeiken J. Charcot joints. By Sidney N. Eichenholtz, M.A., M.D., F.A.C.S., Assistant Clinical Professor of Orthopaedic Surgery, Cornell University School of Medicine, New York, N.Y. With a Foreword by Philip D.Wilson, M.D. Cloth, $ 15,75. Pp.228, with 73 figures. Springfield, Ill., Thomas, 1966. Radiology. 1966;88:1175.
  6. Johnson JTH. Neuropathic fractures and joint injuries. J Bone Joint Surg. (Am) 1967;49–A:1–30.
  7. Sinha S, Munichoodappa CS, Kozak GP. Neuro-arthropathy (Charcot joints) in diabetes mellitus. Medicine (Baltimore) 1972;51:191–210.
  8. Meyn M, Yablon I. Idiopathic arthropathy of the elbow. Clin Orthop Rel Res. 1973;97:90–3.
  9. Classen JN, Rolley RT, Carneiro R, Martire JR. Management of foot conditions of the diabetic patient. Am Surg. 1976;42:81–8.
  10. Wukich DK, Sung W, Wipf SAM, Armstrong DG. The consequences of complacency: managing the effects of unrecognized Charcot feet. Diabet Med. 2011;28:195–8.
  11. Edmonds ME, Watkins PJ. The Charcot joint: understanding its natural history leads to new treatment and prevention. Abstract. Diabet Med. 1984;1:144A.
  12. Shibata T, Tada K, Hashizume C. The results or arthrodesis of the ankle for leprotic neuroarthropathy. J Bone Joint Surg Am. 1990;72–A:749–56.
  13. Dutta P, Bhansali A, Singh P, Mittal BR. Charcot’s foot: advanced manifestation of diabetic neuropathy. Postgrad Med J. 2004;80:434.
  14. Chen HW, Su DH, Chuang LM, Wang CY, Chen HW, Tai TY. Neuropathic osteoarthropathy (Charcot’s foot) as a chronic complication of diabetes – a case report. Tzu Chi Med J. 2005;17:287–90.
  15. Edmonds ME, Petrova NL, Elias D. The earliest magnetic resonance imaging sign of mid-foot Charcot osteoarthropathy is oedema of subchondral (subcortical) bone marrow which needs prompt therapeutic offloading. Abstract. Diabet Med. 2005;22 Suppl 2:93.
  16. Kiuru MJ, Philajamaki HK, Hietanen HJ, Ahovuo JA. MR imaging, bone scintigraphy, and radiography in bone stress injuries of the pelvis and the lower extremity. Acta Radiol. 2002;43:207–12.
  17. Kiuru MJ, Philajamaki HK, Ahovuo JA. Bone stress injuries. Acta Radiol. 2004;45:317–26.
  18. Arapostathi C,Tentolouris N, Jude EB. Charcot foot associated with chronic alcohol abuse. BMJ Case Rep. 2013, doi:10.1136/bcr-2012–008263.
  19. Chantelau E, Richter A, Schmidt-Grigoriadis P, Scherbaum WA. The diabetic Charcot foot: MRI discloses bone stress injury as trigger mechanisms of neuroarthropathy. Exp Clin Endocrinol Diabetes. 2006;114:118–23.
  20. Edmonds ME, Petrova NL, Edmonds AE, Elias DA. What happens to the initial bone marrow oedema in the natural history of Charcot osteoarthropathy? Abstract. Diabetologia. 2006;49 Suppl 1:684.
  21. Chantelau EA, Richter A. The acute diabetic Charcot foot managed on the basis of magnetic resonance imaging- a review of 71 cases. Swiss Med Wkly. 2013;143:w13831.
  22. Ruotolo V, DiPietro B, Giurato L, Masala S, Meloni M, Schillaci O, et al. A new natural history of Charcot foot. Clin Nucl Med. 2013;38:506–9.
  23. Bolacchi F, Uccioli L, Masala S, Giurato L, Ruotolo V, Meloni M, et al. Proton magnetic resonance spectroscopy in the evaluation of patients with acute Charcot neuro-osteoarthropathy. Eur Radiol. 2013;23:2807–13.
  24. Greenstein AS, Marzo-Ortega H, Emery P, O’Connor P, McGonagle D. Magnetic resonance imaging as a predictor of progressive joint destruction in neuropathic joint disease. Arthritis Rheum. 2002;46:2814–6.
  25. Valabhji J. Immunosuppression therapy posttransplantation can be associated with a different clinical phenotype for diabetic Charcot foot neuroarthropathy. Online letter. Diabetes Care. 2011;34:e135.
  26. Kimmerle R, Chantelau E. Weight-bearing intensity produces Charcot deformity in injured neuropathic feet in diabetes. Exp Clin Endocrinol Diabetes. 2007;115:360–4.
  27. Chantelau E, Poll LW. Evaluation of the diabetic Charcot foot by MR imaging and plain radiography– and observational study. Exp Clin Endocrinol Diabetes. 2006;114:428–31.
  28. Halstead J, Bergin D, Keenan AM, Madden J, McGonagle D. Ligament and bone pathologic abnormalities more frequent in neuropathic joint disease in comparison with degenerative arthritis of the foot and ankle. Arthritis Rheum. 2010;62:2353–8.
  29. Peicha G, Preidler KW, Lajtai G, Seibert FJ, Grechenig W. [Reliability of conventional radiography, CT and MRI in the diagnosis of acute hyperflexion trauma to the foot. A prospective clinical study]. Unfallchirurg. 2001;1004:1134–9. German.
  30. Haapamaki VV, Kiuru MJ, Koskinen SK. Ankle and foot injuries: analysis of MDCT findings. Am J Roentgenol. 2004;183:615–22.
  31. Kaissar Yammine, Yahia Fathi. Ankle “sprains” during sport activities with normal radiographs: incidence of associated bone and tendon injuries on MRI findings and its clinical impact. The Foot. 2011;21:176–8.
  32. Tins BJ, Cassar-Pullicino VN. Non-infective inflammatory bone marrow disease. In: A. Baur-Melnyk (ed.), Magnetic Resonance Imaging of the Bone Marrow. Medical Radiology. Diagnostic Imaging. Berlin Heidelberg: Springer; 2013. p. 311–35.
  33. Kainberger F, Peloschek P, Weidekamm C, Uffmann M. [Overuse syndromes of the foot]. Radiologe. 2007;47:210–5. German
  34. Krüger K, Heindel W, Burger C, Brochhagen HG, Prokop A, Lackner K. [MR tomographic imaging of uncomplicated secondary fracture healing: distal radius fracture as an example]. Fortschr Röntgenstr. 1999;170:262–8. German.
  35. Claes L, Recknagel S, Ignatius A. Fracture healing under healthy and inflammatory conditions. Nat Rev Rheumatol. 2012;8:133–43.
  36. Schmidt-Bleek K, Schell H, Schulz N, Hoff P, Perka C, Buttgereit F, et al. Inflammatory phase of bone healing initiates the regenerative healing cascade. Cell Tissue Res. 2012;347:567–73.
  37. Pearson RG, Shu KSS, Lowe J, Game FL, Jeffcoate WJ, Scammell BE. Histological features of acute Charcot neuroarthropathy in diabetes. Abstract. Diabetologia. 2011;54 Suppl 1: S11.
  38. LaFontaine J, Shibuya N, Sampson HW, Valderrama P. Trabecular quality and cellular characteristics of normal, diabetic, and Charcot bone. J Foot Ankle Surg. 2011;50:648–53.
  39. Rein S, Hanisch U, Rammelt S, Schmidt G, Schaller HE, Zwipp H, et al. Histopathological, radiological and clinical aspects of the temporal assignment of scaphoid non-union. Arch Orthop Trauma Surg. 2010;130:1243–50.
  40. Yamamoto T, Schneider R, Bullough PG. Subchondral insufficiency fracture of the femoral head: histopathologic correlation with MRI. Skeletal Radiol. 2001;30:247–54.
  41. Yamamoto T, Iwamoto Y, Schneider R, Bullough PG. Histopathological prevalence of subchondral insufficiency fracture of the femoral head. Ann Rheum Dis. 2008;67:150–3.
  42. Zampa V, Bargelli I, Rizzo L, Turini F, Ortori S, Piaggesi A, et al. Role of dynamic MRI in the follow-up of acute Charcot foot in patients with diabetes mellitus. Skeletal Radiol. 2011;40:991–9.
  43. Vanhoenacker FM, Eyselbergs M, Demeyere A. Bone marrow changes in acute and chronic trauma. In: A.Baur-Melnyk (ed.) Magnetic Resonance Imaging of the Bone Marrow. Medical Radiology. Diagnostic Imaging. Berlin Heidelberg. Springer; 2013: p. 265–92.
  44. Schmid MR, Hodler J, Viennen P, Binkert CA, Zanetti M. Bone marrow abnormalities of foot and ankle: STIR versus T1–weighted contrast enhanced fat-suppressed spin-echo MR imaging. Radiology. 2002;224:463–9.
  45. Edmonds ME, Edmonds A, Elias D, Petrova NL. CT scans reveal the full extent of bone and joint damage of the Charcot foot. Abstract. Diabet Med. 2010;27 Suppl 1:18.
  46. Armstrong DG, Todd WF, Lavery LA, Harkless LB, Bushman TR. The natural history of acute Charcot’s arthropathy in an diabetic foot specialty clinic. Diabet Med. 1997;14:357–63.
  47. Petrova NL, Dew T, Musto R, Thompson, Sherwoord R, Moniz C, et al. The pro-inflammatory cytokines IL-6 and TNF-alpha fall significantly after three months of casting in patients with Charcot osteoarthropathy and severe bone and joint destruction. Abstract. Diabet Med. 2011;28 Suppl 1:17.
  48. Matzelle MM, Gallant MA, Condon KW, Walsh NC, Manning CA, Stein GS, et al. Resolution of inflammation induces osteoblast function and regulates the Wnt signaling pathway. Arthritis Rheum. 2012;64:1540–50.
  49. Augat P, Claes L. Increased cortical remodelling after osteotomy causes posttraumatic osteopenia. Bone. 2008;43:539–43.
  50. Petrova NL, Bates M, Foster AVM, Edmonds ME. In Charcot osteoarthropathy early offloading prevents bone mineral density falls not only in the Charcot foot but in the contralateral non-Charcot foot. Abstract. Diabetologia. 2005;48 Suppl 1:A 354.
  51. Piaggesi A, Marcocci C, Golia F, Di Gregorio S, Baccetti F, Navalesi R. Markers for Charcot’s neurogenic osteo-arthropathy in diabetic patients. Abstract. Diabetes. 2000;49 Suppl 1: A 32.
  52. Gazis A, Pound N, Macfarlane R, Treece K, Game FL, Jeffcoate WJ. Mortality in patients with diabetic neuroarthropathic osteoarthropathy (Charcot foot). Diabet Med. 2004;21:1243–6.
  53. Kyburz D, Finckh A. The importance of early treatment for the prognosis of rheumatoid arthritis. Swiss Med Wkly. 2013;143:w13865.